Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Genetic Engineering Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 13.6% during the forecast period.
This report presents the market size and development trends by detailing the Genetic Engineering Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Genetic Engineering Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Genetic Engineering Drug industry and will help you to build a panoramic view of the industrial development.
Genetic Engineering Drug Market, By Type:
Monoclonal Antibody
Recombinant Human Erythropoietin
Recombinant Human Interferon
Recombinant Human Growth Hormone
Recombinant Human Insulin
Genetic Engineering Drug Market, By Application:
＜30 Years Old
30 Years Old-60 Years Old
＞60 Years Old
Some of the leading players are as follows:
GeneScience Pharmaceuticals Co., Ltd
Beijing SL Pharmaceutical Co., Ltd
Anhui Anke Biotechnology (Group) Co., Ltd
Jiangsu Sihuan Bioengineering Co., Ltd
Shanghai Lansheng Guojian Pharmaceutical Co, Ltd.
Shenzhen Neptunus Interlong Bio-Technique Co., Ltd
Tonghua Dongbao Pharmaceutical Co., Ltd
Shanghai Lansheng Guojian Pharmaceutical Co., Ltd
Biotech Pharmaceutical Co., Ltd
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Genetic Engineering Drug Market: Technology Type Analysis
-
4.1 Genetic Engineering Drug Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Genetic Engineering Drug Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Monoclonal Antibody
4.3.2 Recombinant Human Erythropoietin
4.3.3 Recombinant Human Interferon
4.3.4 Recombinant Human Growth Hormone
4.3.5 Recombinant Human Insulin
5 Genetic Engineering Drug Market: Product Analysis
-
5.1 Genetic Engineering Drug Product Market Share Analysis, 2018 & 2026
-
5.2 Genetic Engineering Drug Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Genetic Engineering Drug Market: Application Analysis
-
6.1 Genetic Engineering Drug Application Market Share Analysis, 2018 & 2026
-
6.2 Genetic Engineering Drug Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 ＜30 Years Old
6.3.2 30 Years Old-60 Years Old
6.3.3 ＞60 Years Old
7 Genetic Engineering Drug Market: Regional Analysis
-
7.1 Genetic Engineering Drug Regional Market Share Analysis, 2018 & 2026
-
7.2 Genetic Engineering Drug Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 GeneScience Pharmaceuticals Co., Ltd
9.1.1 GeneScience Pharmaceuticals Co., Ltd Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Beijing SL Pharmaceutical Co., Ltd
9.2.1 Beijing SL Pharmaceutical Co., Ltd Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Anhui Anke Biotechnology (Group) Co., Ltd
9.3.1 Anhui Anke Biotechnology (Group) Co., Ltd Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Jiangsu Sihuan Bioengineering Co., Ltd
9.4.1 Jiangsu Sihuan Bioengineering Co., Ltd Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Shanghai Lansheng Guojian Pharmaceutical Co, Ltd.
9.5.1 Shanghai Lansheng Guojian Pharmaceutical Co, Ltd. Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Shenzhen Neptunus Interlong Bio-Technique Co., Ltd
9.6.1 Shenzhen Neptunus Interlong Bio-Technique Co., Ltd Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Tonghua Dongbao Pharmaceutical Co., Ltd
9.7.1 Tonghua Dongbao Pharmaceutical Co., Ltd Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Shanghai Lansheng Guojian Pharmaceutical Co., Ltd
9.8.1 Shanghai Lansheng Guojian Pharmaceutical Co., Ltd Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Biotech Pharmaceutical Co., Ltd
9.9.1 Biotech Pharmaceutical Co., Ltd Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
The List of Tables and Figures (Totals 91 Figures and 159 Tables)
Figure Monoclonal Antibody Genetic Engineering Drug market, 2015 - 2026 (USD Million)
Figure Recombinant Human Erythropoietin Genetic Engineering Drug market, 2015 - 2026 (USD Million)
Figure Recombinant Human Interferon Genetic Engineering Drug market, 2015 - 2026 (USD Million)
Figure Recombinant Human Growth Hormone Genetic Engineering Drug market, 2015 - 2026 (USD Million)
Figure Recombinant Human Insulin Genetic Engineering Drug market, 2015 - 2026 (USD Million)
Figure ＜30 Years Old market, 2015 - 2026 (USD Million)
Figure 30 Years Old-60 Years Old market, 2015 - 2026 (USD Million)
Figure ＞60 Years Old market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Genetic Engineering Drug market, by country, 2015 - 2026 (USD Million)
-
Table North America Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table North America Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table North America Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table Canada Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table Canada Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Europe Genetic Engineering Drug market, by country, 2015 - 2026 (USD Million)
-
Table Europe Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table Europe Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table Europe Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table Germany Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table Germany Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table France Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table France Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table Italy Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table Italy Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table Spain Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table Spain Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Genetic Engineering Drug market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table China Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table China Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table Japan Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table Japan Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table India Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table India Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Genetic Engineering Drug market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table MEA Genetic Engineering Drug market, by country, 2015 - 2026 (USD Million)
-
Table MEA Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table MEA Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table MEA Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Genetic Engineering Drug market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Genetic Engineering Drug market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Genetic Engineering Drug market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table GeneScience Pharmaceuticals Co., Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Beijing SL Pharmaceutical Co., Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Anhui Anke Biotechnology (Group) Co., Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Jiangsu Sihuan Bioengineering Co., Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Shanghai Lansheng Guojian Pharmaceutical Co, Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Shenzhen Neptunus Interlong Bio-Technique Co., Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Tonghua Dongbao Pharmaceutical Co., Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Shanghai Lansheng Guojian Pharmaceutical Co., Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biotech Pharmaceutical Co., Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
